Promoter-Based Expression Profiling of Drugs Targeting the Epidermal Growth Factor Receptor Pathway (IMAGE)
Caption
This is a comparison of U0126 -- and wortmannin-treatment profiles -- activity monitored by CAGE (on the left) and microarray (on the right).
Credit
RIKEN
Usage Restrictions
None
License
Licensed content